Survival estimates are reported in the Fig. There were 192 patients (47%) who were deemed ineligible for or declined treatment. Reintervention was common and occurred at a significantly higher rate in the hybrid group compared with other groups (rates for hybrid, endovascular, partial, and open were 46%, 28%, 26%, and 18%, respectively).
Objective: The use of duplex ultrasound for surveillance after fenestrated endovascular aneurysm repair (FEVAR) is not well studied. Our objective was to further characterize normal and abnormal duplex ultrasound findings in renal branch grafts after FEVAR.
Methods: We retrospectively reviewed a single-center experience involving consecutive patients treated with the Zenith fenestrated endovascular graft (ZFEN) device (Cook Medical, Bloomington, Ind) . Postoperative imaging with computed tomography (CT) angiography was obtained at usual intervals. As experience progressed, duplex ultrasound was obtained in a nonstandardized protocol, particularly in patients with reduced renal function. Loss of renal patency was defined as occlusion or stenosis >50%.
Results: A total of 116 patients were treated with FEVAR, of whom 60 (51.7%) had concurrent CT and renal duplex ultrasound images available for review. Six patients (10%) had limited ultrasound studies because of bowel gas and were excluded. This left a total of 94 renal stents placed in 54 patients with a mean follow-up of 23 months. Twelve cases of renal patency loss in 10 patients (9 stenoses, 3 occlusions) were found on CT, 11 (91.6%) of which had concurrent abnormalities found on ultrasound. Stents with compression at the fenestration junction exhibited elevated mean peak systolic velocities (PSVs) compared with nonstenosed stents (349.2 vs 115.3 cm/s; P ¼ .003). Stenosis in the most proximal portion of the stent (ie, within the main body) showed no difference in proximal PSVs (86.0 vs 131.9 cm/s; P ¼ .257) but showed significantly dampened PSVs in the mid (17.5 vs 109.9 cm/s; P ¼ .027) and distal (19.0 vs 78.3 cm/s; P ¼ .028) segments compared with nonstenosed stents. All occluded stents demonstrated no flow detection. Proximal PSV served as a strong classifier for junctional stenosis (area under the curve, 0.98; Fig) . A combined criterion of proximal PSV >215 cm/s or distal PSV <25 cm/s resulted in a sensitivity of 91.6% and specificity of 85.3% for detecting patency loss. All stents underwent successful reintervention. Seven of 10 (70%) patients had detectable >25% increase in serum creatinine concentration associated with renal patency loss.
Conclusions: Duplex ultrasound is a clinically useful modality for surveillance of renal branch grafts after FEVAR. Patterns of segmental velocity elevation (proximal PSV >215 cm/s) and dampening in the distal renal segment indicate potential hemodynamic compromise, and those patients should be considered for secondary intervention. Objective: Treatment of type B aortic dissections with thoracic endovascular aortic repair (TEVAR) has been adopted in many centers with the goal of covering the proximal entry tear. Coverage of the left subclavian artery is commonly required to achieve a dissection-free proximal seal zone. A novel thoracic single side-branched (TSSB) endograft offers a potential off-the-shelf option to achieve total endovascular incorporation of the left subclavian artery during zone 2 TEVAR. The aim of this study was to determine what percentage of patients with type B aortic dissection who require zone 2 TEVAR meet the anatomic requirements for this device.
Methods: All consecutive patients undergoing TEVAR for type B aortic dissections at a single institution from 2006 to 2016 were evaluated. Three-dimensional centerline reconstruction of preoperative computed tomography angiography was performed to identify the diameter of the aorta, distances between branch vessels, diameter of the target branch vessel, and location of the primary entry tear. Only patients who required zone 2 TEVAR were included in the analysis. The primary outcome was percentage of patients who met all anatomic requirements for the TSSB endograft. The specific requirements leading to nonsuitability were also calculated. e36 Abstracts
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